Home
>
National Drug Code (NDC)
>
Brevital Sodium
Brevital Sodium - 42023-106-01 - (methohexital sodium)
Drug Information of Brevital Sodium
| Product NDC: | 42023-106 |
| Proprietary Name: | Brevital Sodium |
| Non Proprietary Name: | methohexital sodium |
| Active Ingredient(s): | 2.5 g/1 & nbsp; methohexital sodium |
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS; RECTAL |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Brevital Sodium
| Product NDC: | 42023-106 |
| Labeler Name: | JHP Pharmaceuticals LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA011559 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20071101 |
Package Information of Brevital Sodium
| Package NDC: | 42023-106-01 |
| Package Description: | 1 VIAL in 1 CARTON (42023-106-01) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL |
NDC Information of Brevital Sodium
| NDC Code | 42023-106-01 |
| Proprietary Name | Brevital Sodium |
| Package Description | 1 VIAL in 1 CARTON (42023-106-01) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL |
| Product NDC | 42023-106 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | methohexital sodium |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | INTRAMUSCULAR; INTRAVENOUS; RECTAL |
| Start Marketing Date | 20071101 |
| Marketing Category Name | NDA |
| Labeler Name | JHP Pharmaceuticals LLC |
| Substance Name | METHOHEXITAL SODIUM |
| Strength Number | 2.5 |
| Strength Unit | g/1 |
| Pharmaceutical Classes | Barbiturate [EPC],Barbiturates [Chemical/Ingredient] |
